Literature DB >> 1372426

Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate.

D E Neal1, S Clejan, D Sarma, T D Moon.   

Abstract

Prostate specific antigen (PSA) has become a mainstay in the diagnosis and management of patients with prostate cancer. We have found, as have others, that it may be elevated in patients with prostatic inflammation. Ten patients had clinical evidence of prostatitis and elevated PSA levels. Six of these had persistently elevated levels after antibiotic treatment. After transrectal ultrasonography and biopsy, two had findings of adenocarcinoma, and the rest had a pathologic diagnosis of acute or chronic prostatitis. We studied this process in an experimental model of prostatitis using a nonhuman primate. We infected six cynomolgus monkeys and followed their PSA levels until resolution of the infection. The PSA peaked between 5 and 7 days after inoculation and gradually returned to baseline in 8 weeks. The dramatically elevated serum PSA levels in bacterial prostatitis can cause confusion in the diagnosis of prostatic carcinoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372426     DOI: 10.1002/pros.2990200205

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  16 in total

1.  [Modification of the histopathologic degree of inflammation in asymptomatic prostatitis (NIH IV) by moxifloxacin].

Authors:  T Bschleipfer; F M E Wagenlehner; W Weidner
Journal:  Urologe A       Date:  2007-09       Impact factor: 0.639

2.  Psychological impact of serial prostate-specific antigen tests in Japanese men waiting for prostate biopsy.

Authors:  Minoru Kobayashi; Akinori Nukui; Takao Kamai
Journal:  Int J Clin Oncol       Date:  2016-09-08       Impact factor: 3.402

Review 3.  Prostate kallikrein markers in diagnosis, risk stratification and prognosis.

Authors:  David Ulmert; M Frank O'Brien; Anders S Bjartell; Hans Lilja
Journal:  Nat Rev Urol       Date:  2009-07       Impact factor: 14.432

4.  Relationship between prostate specific antigen density, microvessel density and prostatic volume in benign prostatic hyperplasia and advanced prostatic carcinoma.

Authors:  M Cetinkaya; S Günçe; E Ulusoy; F Aksoy; O Yildiz; O Adsan; C Ozden
Journal:  Int Urol Nephrol       Date:  1998       Impact factor: 2.370

5.  Effect of prostatitis on lower urinary tract symptoms: retrospective analysis of prostate biopsy tissue.

Authors:  Jai Hyun Chung; Ji Hyeong Yu; Luck Hee Sung; Chung Hee Noh; Jae Yong Chung
Journal:  Korean J Urol       Date:  2012-02-20

6.  Changes in serum prostate-specific antigen after treatment with antibiotics in patients with lower urinary tract symptoms/benign prostatic hyperplasia with prostatitis.

Authors:  Yoon-Soo Kyung; Hyeoung-Cheol Lee; Hyung-Jee Kim
Journal:  Int Neurourol J       Date:  2010-08-31       Impact factor: 2.835

7.  Relationship between serum prostate specific antigen and the pattern of inflammation in both benign and malignant prostatic disease in Middle Eastern men.

Authors:  J T Anim; E O Kehinde; A Prasad; M Sheikh; O A Mojiminiyi; Y Ali; K Al-Awadi
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

8.  Serum prostate specific antigen changes in cynomolgus monkeys (Macaca fascicularis) on a high sugar high fat diet.

Authors:  James N Mubiru; Magdalena Garcia-Forey; Nicole Cavazos; Peggah Hemmat; Edward J Dick; Michael A Owston; Cassondra A Bauer; Robert E Shade; Jeffrey Rogers
Journal:  Prostate       Date:  2011-06-28       Impact factor: 4.104

9.  A prospective study of reducing unnecessary prostate biopsy in patients with high serum prostate-specific antigen with consideration of prostatic inflammation.

Authors:  An Gu Lee; Yong Hyeuk Choi; Sung Yong Cho; In Rae Cho
Journal:  Korean J Urol       Date:  2012-01-25

10.  Prostate-specific antigen density--a reliable parameter for the detection of prostate cancer?

Authors:  W F Thon; F Gadban; M C Truss; M Kuczyk; U Hartmann; U Jonas
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.